Here you will find a selection of articles that have been published in international peer-reviewed journals by the company founder as the initiator.
For products that have already received market approval, we conduct clinical studies in which the medical benefits and safety of the products are demonstrated. We publish the study results with you in high-ranking international journals and support you in ensuring that your product is reimbursed by the health insurance funds (see also medical aids register). Our customers use the study results to market their medical devices efficiently.
Recently, in an international retrospective clinical evaluation, we demonstrated the benefits and safety of a medical device for dynamic standing. The publication has been very well received by the research community and is being used efficiently by our customers to market the medical device. We also successfully published the results of a prospective study of a novel non-invasive medical device that caused patients with an elevated cardiovascular risk profile to lose weight over a long period of time (more than 2 years).
Medical translational research takes up problems related to our patients into the lab. Here, a multi-disciplinary team in basic science helps to make results useful for practical applications to enhance our understanding of disease, develop new diagnostics and translate our findings into new therapeutic options. Curiosity, precision, well-founded and sound scientific knowledge with a good feeling for relevant problems characterise academic research with clinical applicability. It is now well-known that circulating angiogenic cells play an indispensible role in vascular regeneration and organ preservation. Our work has been reproduced and cited manifold.
Pattern of clinical disease caused by human parvovirus B19 (B19V) is generally a self-limiting subclinical disorder. However, in certain individuals B19V is a fatal disease. B19 V is the most common viral pathogen associated with inflammatory cardiomyopathy. Interestingly, B19V infection is restricted to cardiac endothelial cells, but not cardiomyocytes in this disease. B19V infection of endothelial cells results in apoptosis, the programmed cell death. Patients with B19V cardiomyopathy present endothelial dysfunction and show elevated numbers of circulating apoptotic endothelial cells. How can B19V persist in the heart over long time periods? What are the mechanisms of damage in B19V-infected bone marrow-derived cells? These findings are being published shortly in a high-ranking journal.
The ACE-Study was widely acclaimed and received great international interest. This investigator-initiated study broadened the indication of Enoxaparin. In this randomised, prospective multicentre-study, Enoxaparin showed non-inferior to unfractionated heparin and phenprocoumon in TEE-guided cardioversion of persistent non-valvular atrial fibrillation.
Recognition among Experts.
Harrison's Principles of Internal Medicine in its 18th edition is widely regarded as one of the most authoritative American books on internal medicine and has been described as the "most recognised book in of medicine". This encyclopaedia has been translated and adapted for the German-speaking countries by around 300 specialists. Two innovative chapters have been entrusted to the founder’s care in two consecutive editions.
Digitalisation of the health market most likely is a similar revolution as antibiotics have been in the past. Medical apps increasingly influence our behaviour. Despite huge amounts of medical apps on the market, only a small minority has proven evidence or complies with German or European regulations as medical device. We provide assistance and services for developers and companies to tackle the challenges for this disruptive technology.
With over 1000 questions of pharmacology of internal medicine and cardiology, medical students specifically prepare themselves for oral examinations and effectively keep the knowledge for their patients. – in German
Principles and Practice of Panvascular Medicine is a comprehensive textbook by the editors Peter Lanzer and Eric J. Topol. It covers cardiology, cardiac surgery, vascular surgery, radiology, neurology, neurosurgery, and vascular medicine (angiology), thus providing an interdisciplinary and integrated perspective of modern vascular medicine. It is aimed at junior practitioners and experts. The founder was entrusted to contribute to fundamental areas arterial disease.
© 2021 MEDIACC GmbH